[단독 최초]
세계최초 ‘난치성 T세포 림프종 혈액암 치료법’ 발표
***** 경보제약 (214390)

젬시타빈, 코판리십 병용투여 
경보제약 ,  젬시타빈 염산염 원료사 
식약처 확인

세계최초 난치성 혈액암 치료법 밝혀 
 http://www.mdtoday.co.kr/mdtoday/index.html?no=410844


https://nedrug.mfds.go.kr/searchDrug?sort=&sortOrder=false&searchYn=&page=1&searchDivision=detail&itemName=%EC%A0%AC%EC%8B%9C%ED%83%80%EB%B9%88&entpName=&ingrName1=&ingrName2=&ingrName3=&itemSeq=&stdrCodeName=&atcCodeName=&indutyClassCode=&sClassNo=&narcoticKindCode=&cancelCode=&etcOtcCode=&makeMaterialGb=&searchConEe=AND&eeDocData=&searchConUd=AND&udDocData=&searchConNb=AND&nbDocData=&startPermitDate=&endPermitDate=